Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients
Retracted Article 2014 en
Authors
DM
Deepti Malhotra
RT
Rajesh K. Thimmulappa
NM
Nicolas Mercado
Abstract
1 min read
The JCI, with the agreement of the corresponding authors and coauthors, is retracting the article "Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients."The IP: streptavidin/IB: anti-HDAC2 immunoblot panel in Figure 3B was recently identified as an inverted image of the right four lanes of the anti-H4 acetyl CHIP gel presented in Figure 2A.Additionally, the IP: anti-streptavidin/IB: anti-DDK immunoblot presented in Supplemental Figure 3A was identified as an inverted image of the left four lanes of the anti-H4 acetyl CHIP gel presented in Figure 2A.Further, in Figure 9B, the incorrect anti-HDAC2 immuno blot was presented.
Deepti Malhotra, Rajesh K. Thimmulappa, Nicolas Mercado, Kazuhiro Ito, Ponvijay Kombairaju, Sarvesh Kumar, Jinfang Ma, David Feller‐Kopman, Robert A. Wise, Peter J Barnes, Shyam Biswal
Jeffrey Clarke, Thomas E. Stinchcombe, Jeffrey Crawford, Hirva Mamdani, Lin Gu, Neal Ready, Andrew B. Nixon, Stephen Baleviic, Michael J. Campa, Liz Gottlin, Ryan T. Bushey, James E. Herndon, Scott Antonia, Edward F. Patz, George R. Simon
Rémi Porte, Rita Silva-Gomes, Charlotte Théroude, Raffaella Parente, Fatemeh Asgari, Marina Sironi, Fabio Pasqualini, Sonia Valentino, Rosanna Asselta, Camilla Recordati, Marta Monari, Andrea Doni, Antonio Inforzato, Carlos Rodríguez‐Gallego, Ignacio Obando, Elena Colino, Barbara Bottazzi, Alberto Mantovani
Discussion(0)
No comments yet. Be the first to comment.